PL386381A1 - Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów - Google Patents

Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów

Info

Publication number
PL386381A1
PL386381A1 PL386381A PL38638108A PL386381A1 PL 386381 A1 PL386381 A1 PL 386381A1 PL 386381 A PL386381 A PL 386381A PL 38638108 A PL38638108 A PL 38638108A PL 386381 A1 PL386381 A1 PL 386381A1
Authority
PL
Poland
Prior art keywords
obtaining
active formulations
lyophilized active
pharmacological form
stable pharmacological
Prior art date
Application number
PL386381A
Other languages
English (en)
Other versions
PL213166B1 (pl
Inventor
Ewa Zuziak
Andrzej Gamian
Andrzej Górski
Tomasz Lipiński
Original Assignee
Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk filed Critical Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Priority to PL386381A priority Critical patent/PL213166B1/pl
Priority to PCT/PL2009/050032 priority patent/WO2010050833A2/en
Priority to US13/059,815 priority patent/US9238798B2/en
Priority to EP09775370.1A priority patent/EP2340304B1/en
Priority to ES09775370.1T priority patent/ES2619521T3/es
Publication of PL386381A1 publication Critical patent/PL386381A1/pl
Publication of PL213166B1 publication Critical patent/PL213166B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL386381A 2008-10-29 2008-10-29 Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów PL213166B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL386381A PL213166B1 (pl) 2008-10-29 2008-10-29 Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów
PCT/PL2009/050032 WO2010050833A2 (en) 2008-10-29 2009-10-29 A method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages
US13/059,815 US9238798B2 (en) 2008-10-29 2009-10-29 Method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages
EP09775370.1A EP2340304B1 (en) 2008-10-29 2009-10-29 A method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages
ES09775370.1T ES2619521T3 (es) 2008-10-29 2009-10-29 Un método para producir una forma farmacológicamente estable de preparaciones activas liofilizadas de bacteriófagos purificados

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL386381A PL213166B1 (pl) 2008-10-29 2008-10-29 Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów

Publications (2)

Publication Number Publication Date
PL386381A1 true PL386381A1 (pl) 2010-05-10
PL213166B1 PL213166B1 (pl) 2013-01-31

Family

ID=41796512

Family Applications (1)

Application Number Title Priority Date Filing Date
PL386381A PL213166B1 (pl) 2008-10-29 2008-10-29 Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów

Country Status (5)

Country Link
US (1) US9238798B2 (pl)
EP (1) EP2340304B1 (pl)
ES (1) ES2619521T3 (pl)
PL (1) PL213166B1 (pl)
WO (1) WO2010050833A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3002948B1 (fr) * 2013-03-06 2017-09-08 Colcom Procede de capture de virus.
DE102013106455A1 (de) 2013-06-20 2014-12-24 Airbus Defence and Space GmbH Verfahren zur Dekontamination von bakteriologischen Verunreinigungen
CN109837251B (zh) * 2017-11-27 2022-01-28 菲吉乐科(南京)生物科技有限公司 一种噬菌体保护剂及其制备方法和应用
CN108651522A (zh) * 2018-04-09 2018-10-16 广州诺晶生物技术有限公司 一种溶藻弧菌噬菌体制剂、制备方法及其应用
CN112940942A (zh) * 2021-04-09 2021-06-11 江苏省农业科学院 一种高耐热稳定剂、微生物制剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
RU2059723C1 (ru) * 1993-05-20 1996-05-10 Всероссийский научно-исследовательский институт физиологии, биохимии и питания сельскохозяйственных животных Способ получения фагового препарата "стрептофагин"
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
WO2002038104A2 (en) * 2000-11-13 2002-05-16 Iowa State University Research Foundation, Inc. Compositions and methods for reducing the amount of salmonella in livestock
ATE421249T1 (de) * 2002-02-13 2009-02-15 Immunology Lab Inc Zusammensetzungen und verfahren für die behandlung von mikroorganismen-infektionen
AU2005301048A1 (en) * 2004-11-02 2006-05-11 Chr. Hansen A/S Bacteriophage compositions
EP1854478A1 (en) * 2006-05-12 2007-11-14 Cytos Biotechnology AG Nicotine-carrier vaccine formulation
PL212099B1 (pl) * 2007-02-09 2012-08-31 Inst Immunologii I Terapii Doświadczalnej Pan Oczyszczony preparat bakteriofagowy, sposób jego otrzymywania i zastosowanie

Also Published As

Publication number Publication date
US20110256103A1 (en) 2011-10-20
PL213166B1 (pl) 2013-01-31
WO2010050833A3 (en) 2010-06-24
ES2619521T3 (es) 2017-06-26
EP2340304B1 (en) 2016-12-21
EP2340304A2 (en) 2011-07-06
WO2010050833A2 (en) 2010-05-06
US9238798B2 (en) 2016-01-19

Similar Documents

Publication Publication Date Title
IL238337A0 (en) A process for the preparation of pharmaceutical active compounds
SMT201600254B (it) Procedimento per la preparazione di idromagnesite
IL214396A (en) Anti-viral anti-viral nucleosides, pharmaceutical preparations containing them and methods for their preparation, as well as their preparation of antiviral intermediates
EP2400918A4 (en) SYSTEM AND METHODS FOR MAINTAINING SPACE FOR INCREASE IN THE ALVEOLAR RIDGE
EP2207802A4 (en) INTRANASAL ADMINISTRATION OF ACTIVE AGENTS ON THE CENTRAL NERVOUS SYSTEM
EP2398483A4 (en) Oxyntomodulin Analogs
PL2358669T3 (pl) Alfa-ketonadkwasy oraz metody ich produkcji i wykorzystywania
PL2373681T3 (pl) Kompozycje farmaceutyczne albiglutydu
EP2444398A4 (en) NEW INTERMEDIATE PRODUCTS FROM VORICONAZOLE AND PRODUCTION PROCESS FOR VORICONAZOLE THEREWITH
SI2243145T1 (sl) Kompozitni izolator za kontrolo električnega polja
ZA201204759B (en) Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
IL201465A0 (en) Self-precipitating pharmaceutical formulations for the modified release of active principle
ZA201009153B (en) Use of pyrimidylaminobenzamide derivatives for the treatment for the treatment of fibrosis
IL206577A0 (en) Formulations of flibanserin
PL386381A1 (pl) Sposób otrzymywania farmakologicznej stabilnej formy zliofilizowanych aktywnych preparatów oczyszczonych bakteriofagów
PL2502635T3 (pl) Połączone preparaty do leczenia męskiej niepłodności
IT1395355B1 (it) Procedimento per la preparazione di una miscela bituminosa ad elevata lavorabilita'
IL212850A0 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained
HU1000565D0 (en) Process for the preparation of pharmaceutically active compound and intermediers
PT2488158E (pt) Formulações medicinais melhoradas, em forma de aerossol
IL211407A0 (en) Controlled-released peptide formulations
SI2331098T1 (sl) Postopki za dajanje iloperidona
FR2948680B1 (fr) Nouveaux mutants de la pqq s-gdh
EP2328885A4 (en) Alpha-Crystalline Form Substituted Selenoxanthene and the Method of Making the Same
ITMI20080888A1 (it) Procedimento per la preparazione di zileuton